More than 60,000 volunteers have received one of the four Chinese candidates for the coronavirus vaccine “without presenting significant adverse effects,” said a senior official from the Ministry of Science and Technology of that country today.
Executive press conference on the advancement of vaccines in China, the deputy director of the Department of Social Development of that firm, Tian Baoguo, said that there are already 13 vaccines partially or totally developed by the Asian country in phase 3 of clinical trials.
“Adverse effects are common and normal in a vaccine candidate. Of the 60,000 people who have received the vaccine, some have had mild adverse effects , such as swelling at the vaccination site or fever, but no serious side effects have been reported. “, he indicated.
At the same press conference, the president of the state-owned China National Biotechnology Group (CNBG, part of the pharmaceutical giant Sinopharm), Liu Jingzhen, assured that the conglomerate is ready for mass production of the vaccine , once they are finished. testing, and that it has the capacity to manufacture more than 1 billion doses in 2021 .
For his part, the director of the Center for the Development of Science and Technology of the National Health Commission, Zheng Zhongwei, indicated that the price “will vary” depending on the type of vaccine , although “it will not be determined by supply and demand. but because of the technology used and the cost and scale of production “. ”
It will be an acceptable price for the general public . The inactivated vaccine will cost more than the rest,” Zheng said. Also, the official denied that China has launched a “vaccine diplomacy” with all the tests that the country carries out in various countries , many of them developing .
GIPHY App Key not set. Please check settings